- Lupin founder-chairman Desh Bandhu Gupta dies at 79 27 June 2017
- Lupin gets US FDA nod for marketing generic Percocet tablets 28 February 2017
- Lupin India's most reputed drug brand; Sun, Cipla follow 18 August 2016
- Lupin to buy 21 brands from Japan's Shionogi for $150 mn 02 August 2016
- Lupin buys US generics drug maker Gavis for $880 mn 23 July 2015
- 3 Indian firms get FDA nod to sell generic hypertension drug 07 January 2015
- Lupin ties up with Salix to sell US firm's drugs in Canada 13 September 2014
- Lupin acquires Dutch injectable company Nanomi BV 04 February 2014
- Lupin Q4 net slightly up at Rs249 crore 10 May 2012
- Lupin's Q3 net rises nearly 5 per cent to Rs235 crore 24 January 2012
- Lupin to acquire Japan's I'rom Pharmaceutical 17 November 2011
- Lupin, Sanofi-Aventis Philippines in strategic agreement 05 September 2011
- Jhunjhunwala reduces stake in Lupin 20 July 2011
- Lupin in pact to supply TB drug to Brazil 05 January 2011
- Lupin net profit up 40 per cent in Q4 05 May 2010
- Lupin's sleep disorder drug gets USFDA nod 22 March 2010
- Lupin receives US FDA approval for perindopril erbumine tablets 29 January 2010
- Lupin settles dispute with Forest Labs over Namenda 22 December 2009
- Lupin buys US rights for cholesterol drug Antara 29 September 2009
- Divakar Kaza rejoins Lupin as president, HR 12 December 2008
- Eli Lilly sues Lupin, Aurobindo for patent infringement 03 December 2008
- US FDA observations not to affect drug sales: Lupin 14 November 2008
- Lupin in marketing alliance with Forest for asthma product 19 August 2008
- Lupin gets €20 million from patent deal 13 October 2007
- Lupin acquires Japan''s Kyowa Pharmaceutical 10 October 2007
- Lupin acquires drugs intermediates manufacturer Rubamin Laboratories 28 September 2007
- Lupin to invest Rs200 crore in new plant, capacity addition 10 August 2007
- Lupin awarded tentative US FDA approval for sertraline 02 January 2007
- Lupin gets US FDA approval for Meloxicam 20 July 2006
- Lupin gets US FDA approval for Cefdinir 24 May 2006
- US FDA approves Lupin's cefprozil suspension, Orchid's tablets 20 December 2005
- Lupin places $100-million FCCB 07 December 2005
- Lupin receives US FDA approval for Cephalexin capsules 01 December 2005
- Lupin receives IND approval from DCGI for Desoris LLL-3348 28 November 2005
- FIIs hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma 20 October 2003
- Lupin turns to cephalosporins and cardiovasculars for growth 22 November 1999
